dihydroxycoumarin
Trade name: Esculetin
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Mar 25, 2024 (NCT06329167)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Protein kinase C-like 1INHIBITOR
PKC1 inhibitor
EGFR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06507488 | N/A | Aug 31, 2024 | First People's Hospital of Shenyang |
| NCT06329167 | Phase 4 | Mar 25, 2024 | Jinlin University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| First People's Hospital of Shenyang | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Jinlin University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1